• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN PROTEGE RX CAROTID STENT SYSTEM; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN PROTEGE RX CAROTID STENT SYSTEM; STENT, CAROTID Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Intracranial Hemorrhage (1891); Thromboembolism (2654); Vascular Dissection (3160)
Event Date 01/19/2021
Event Type  Injury  
Manufacturer Narrative
Journal title: direct aspiration thrombectomy experience with the sofia 6f catheter in acute ischemic stroke japanese journal of radiology (2021) 39:605¿610.Https://doi.Org/10.1007/s11604-021-01090-z.If information is provided in the future, a supplemental report will be issued.
 
Event Description
A journal article was submitted detailing a study which aimed to evaluate the usefulness of a non-medtronic (sofia) 6f catheter in mechanical thrombectomy with the direct aspiration first pass technique.148 patients were included in the study.Medtronic¿s spider fx and protégé rx devices were used in the study.During procedures with tandem occlusions (19 patients) the stenotic segment was passed with a guidewire, and spiderfx embolic protection device was deployed in the terminal segment of the cervical ica.Subsequently, emergency percutaneous transluminal balloon angioplasty using a non-medtronic balloon was performed for the stenotic segment.If balloon angioplasty failed to achieve luminal patency, then additional carotid stenting with protege rx was performed to allow mechanical thrombectomy.A protégé rx stent was placed in 2 patients.After achieving adequate luminal patency, the non-medtronic (sofia) 6f was navigated to the thrombus site, and direct aspiration thrombectomy was performed.All patients were followed up in an inpatient setting and evaluated by a multidisciplinary team on a regular basis.Thromboembolic complications in new territories occurred in 8 cases.After treatment, a symptomatic intracranial hemorrhage (sich) was observed in 8 patients.In three cases, intracranial dissection was detected after the use of the stent retriever.The mortality rate after the procedure was 14.1%.There is no established or suspected causal relationship between the device(s) and the death events.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROTEGE RX CAROTID STENT SYSTEM
Type of Device
STENT, CAROTID
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
EI  
091708734
MDR Report Key12343553
MDR Text Key267312156
Report Number2183870-2021-00302
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
Reporter Country CodeTU
PMA/PMN Number
P060001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 08/19/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/19/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/16/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age64 YR
-
-